Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery

British Journal of Anaesthesia

Volumn 92, Issue 2, 2004, Pages 187-194

  Weale, N K ^a   Rogers, C A ^a   Cooper, R ^b   Nolan, J ^a   Wolf, A R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Anaesthesia, paediatric; Analgesics opioid, remifentanil; Complications, congenital heart disease; Protein, neuropeptide Y; Stress, response

Indexed keywords

ADRENALIN; DIAZEPAM; DOPAMINE; GLUCONATE CALCIUM; GLUCOSE; HYDROCORTISONE; ISOFLURANE; NEUROPEPTIDE Y; OPIATE DERIVATIVE; OXYGEN; PANCURONIUM; REMIFENTANIL; SEVOFLURANE;

ANESTHESIA INDUCTION; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; BRADYCARDIA; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEART STRESS; HEART SURGERY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; INFANT; MALE; MEDICAL DOCUMENTATION; NEWBORN; NEWBORN DISEASE; PEDIATRIC SURGERY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TACHYCARDIA; THORAX SURGERY;

EID: 0742324389     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh038     Document Type: Article

References (26)

1. Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992; 326: 1-9
2. Hickey PR, Hansen DD. High-dose fentanyl reduces intraoperative ventricular fibrillation in neonates with hypoplastic left heart syndrome. J Clin Anesth 1991; 3: 295-300
3. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 1990; 73: 661-70
4. 2+ concentrations on neonatal myocardial function after ischemia. J Thorac Cardiovasc Surg 1993; 105: 59-67
5. Purcell-Jones G, Dormon F, Sumner E. The use of opioids in neonates. A retrospective study of 933 cases. Anaesthesia 1987; 42: 1316-20
6. Webster NR. Opioids and the immune system. Br J Anaesth 1998; 81: 835-6
7. Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 1984; 223: 188-90
8. Duncan HP, Cloote A, Weir PM, et al. Reducing stress responses in the pre-bypass phase of open heart surgery in infants and young children: a comparison of different fentanyl doses. Br J Anaesth 2000; 84: 556-64
9. Glass PS, Iselin-Chaves IA, Goodman D, Delong E, Hermann DJ. Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. Anesthesiology 1999; 90: 1556-63
10. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89: 562-73
11. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33
12. Sun LS, Du F, Schechter WS, Quaegebeur JM, Vulliemoz Y. Plasma neuropeptide Y and catecholamines in pediatric patients undergoing cardiac operations. J Thorac Cordiovasc Surg 1997; 113: 278-84
13. Bartlett MS. Properties of sufficiency and statistical tests. Proc Roy Soc 1937; 160 (Series A): 268-82
14. Cook RD, Weisberg S. Diagnostics for heteroscedacity in regression. Biometrika 1983; 70: 1-10
15. Akaike H. A new look at the statistical model identification. IEEE Transact Autonomic Control 1974; AC-19: 716-23
16. Wolf AR, Doyle E, Thomas E. Modifying infant stress responses to major surgery: spinal vs extradural vs opioid analgesia. Paediatr Anaesth 1998; 8: 305-11
17. Davis PJ, Galinkin J, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg 2001; 93: 1380-6
18. Ross AK, Davis PJ, Dear Gd GL, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg, 2001; 93: 1393-401
19. Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth 2001; 13: 407-16
20. Elliott P, O'Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK. Severe cardiovascular depression with remifentanil. Anesth Analg 2000; 91: 58-61
21. Pernow J, Lundberg JM, Kaijser L. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans. J Cardiovasc Pharmacol 1988; 12: 593-9
22. Pernow J, Lundberg JM, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987; 40: 47-54
23. Abrahamsson C. Neuropeptide Y-1 and Y-2 receptor mediated cardiovascular effects in the anaesthetised guinea pig, rat and rabbit. J Cardiovascular Physiol 2000; 36: 451-58
24. Kogner P, Bjork O, Theodorsson E. Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval. Acta Paediatr 1994; 83: 423-7
25. Sun LS, Du F, Schechter WS, Quaegebeur JM, Vulliemoz Y. Plasma neuropeptide Y and catecholamines in pediatric patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997; 113: 278-84
26. Balasubramaniam A. Clinical potentials of neuropeptide Y family of hormones. Am J Surg 2002; 183: 430-4